Addiction Medicine: Beyond the Abstract
Post-Cesarean Analgesia in Women on opioid agonists to treat Opiate Use Disorder

Post-Cesarean Analgesia in Women on opioid agonists to treat Opiate Use Disorder

December 19, 2017

In this episode of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Daniel Alford of Boston Medical Center and Boston University School of Medicine. His new study takes a closer look at the continuation of opiate agonist treatment in the perioperative setting among women undergoing cesarean section. Dr. Alford talks about the study, its limitations and applicability, and how the findings compare to current trends in practice. He also discusses his career in studying and treating patients with these issues.

The Unexpected Urine Test: A Matter Far From Simple

The Unexpected Urine Test: A Matter Far From Simple

January 3, 2018

In episode two of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Stefan Kertesz of the University of Alabama Birmingham and the Birmingham VA Medical Center. In his recent piece from the Journal, Dr. Kertesz discusses the challenge of treating patients who obtain benzodiazepines from another provider in addition to known prescribed opiates. He addresses this issue in the context of the results from a recent study by McClure, et al. in the same issue of the Journal which analyzes patterns of urine drug test results from a national laboratory.

Read more here.

ASAM developed the Appropriate Use of Drug Testing in Clinical Addiction Medicine document to provide guidance about the effective use of drug testing in the identification, diagnosis, treatment and promotion of recovery for patients with, or at risk for, addiction. Click here.

Addressing Stigma in medication Treatment of Adolescents with Opioid Use Disorder

Addressing Stigma in medication Treatment of Adolescents with Opioid Use Disorder

January 3, 2018

In episode three of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Sarah Bagley of Boston Medical Center and Boston University School of Medicine. Her recent commentary addresses the approach clinicians take in treating adolescents with opioid use disorder and perceptions about the use of medication management. She also discusses the recent policy statement by the American Academy of Pediatrics concerning the use of pharmacotherapy with buprenorphine/naloxone, methadone, and naltrexone in this population.

Read more here.

Improving Opioid Addiction Treatment for Pregnant Women

Improving Opioid Addiction Treatment for Pregnant Women

February 16, 2018

In episode four of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Gerald Cochran of the University of Pittsburgh. His recent article details a pilot study which assesses a patient navigation intervention model for pregnant women with opioid use disorder. This represents a novel application for patient navigation. He details the clinical relevance of these techniques and discusses the potential impact of his findings.

 

To read more click here

Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles

Integrating Substance Use Services with Primary Care: Incentives Based on Choice Architecture Principles

April 3, 2018

In episode five of Addiction Medicine: Beyond the Abstract, we are joined by Leo Beletsky, JD, MPH of Northeastern University. His commentary from the latest issue of the journal addresses common challenges that influence the delivery of substance use treatment in the primary care setting. He details underlying concepts of behavioral economics that may impact the decisions made by healthcare providers. Specifically, he addresses choice architecture as it relates to decisions regarding substance use treatment.

 

Read more here.

Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal

Methadone Maintenance Treatment During Incarceration Compared with Forced Withdrawal

May 15, 2018

In episode six of Addiction Medicine: Beyond the Abstract, we are joined by Kelly Moore, Ph.D. of Yale University School of Medicine. Her new study takes a look at the implementation of continued methadone maintenance treatment (MMT) upon incarceration. Often, inmates undergo forced withdrawal once they are placed in a correctional setting. Her study sought to measure the difference in behavior both during incarceration and after release for inmates in a methadone maintenance group compared to those in a forced withdrawal group.

To read the article, click here.

Nicotine Content in E-cigarette liquid: often not as labeled

Nicotine Content in E-cigarette liquid: often not as labeled

June 29, 2018

In episode seven of Addiction Medicine: Beyond the Abstract, we are joined by Barrett Raymond. He is a nurse practitioner and graduate of Brigham Young University. In his recent study, Raymond analyzed e-cigarette liquid samples from popular online manufacturers and distributors in the United States. He compared the expected nicotine content with the measured levels. He also discussed regulatory changes and the potential impact on the industry.

 

To read the full article, click here

Buprenorphine Treatment for Adolescents and Young Adults

Buprenorphine Treatment for Adolescents and Young Adults

September 6, 2018

In episode eight of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Lisa Marsch. She is a professor at Dartmouth and Director of both the Center for Technology and Behavioral Health and the Dartmouth Psychiatric Research Center. In her recent study, Marsch and her colleagues took a look at relevant randomized controlled trials and observational studies which evaluated the use of buprenorphine in adolescents and young adults.

To learn more, click here.

Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios

Perinatal Pharmacokinetics and Serum Methadone/Metabolite Ratios

November 27, 2018

 

In episode nine of Addiction Medicine: Beyond the Abstract, we are joined by Dr. John McCarthy, an associate professor of psychiatry and volunteer clinical faculty at the University of California Davis. In his recent study, Dr. McCarthy and his colleagues examined the significance of serum methadone/metabolite ratios (or MMRs). In particular, they looked at the changes in these ratios for the expecting mother throughout pregnancy and sought to use these ratios to objectively guide methadone dosing.

To read the full article, click here. 

Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

Interest in Reduction or Cessation of Opiate Use Among Syringe Exchange Clients

March 13, 2019

In episode ten of Addiction Medicine: Beyond the Abstract, we are joined by Dr. Caleb Banta-Green, principal research scientist at The Alcohol and Drug Abuse Institute at the University of Washington. In his recent study, Dr. Banta-Green and his colleagues surveyed syringe exchange program (SEP) clients to gauge interest in receiving help with cessation or reduction of opiate use. Data from this study produced valuable conclusions about subgroups that are more likely to take advantage of available interventions.

 

Read more here